Haemophilus. influenzae was early described by Richard Pfeiffer in 1893, all alone during an influenza pandemic. H. influenzae is accomplished only in human beings; it is a facultative anaerobic bacterium.Â
The animal reservoir has just been sourced for H. influenzae. These organisms spread from one person to another by direct contact, secretions, and via aerosol, which they colonize through the nasopharynx. Infected individuals, specifically those left untreated and with infections with poor immunity, spread the disease by respiratory droplets with H. influenzae.Â
Exposure criteria to H. influenzae are more in children. According to the 2017 annual report, the occurrence rate was 1.7 for non-b H. influenzae and 0.18 for Hib, and 1.6 for non-typeable H. influenzae, which affected 100,000 children under five years old. The carriage criteria are approximately 20% in juveniles and 1-year-old babies, increasing to about 50% in 5 years old children.Â
Healthy adults are also infected by Haemophilus influenzae, which spreads and colonizes by aerosol, direct and venereal contact, or through secretions. The colonization rate is higher in nontyable H. influenzae compared to type b H. influenzae. But still, both types multiply quickly and maintain a higher growth rate.Â
Scientific classification:Â Â
Kingdom: Bacteria Â
Phylum: Proteobacteria Â
Class: Gammaproteobacteria Â
Order: Pasteurellales Â
Family: Pasteurellaceae Â
Genus: Haemophilus Â
Species: Haemophilus influenzae Â
Structure:Â
Six known antigenic types of Haemophilus influenzae are identified by their capsular polysaccharides, which are important virulence factors. The six types are:Â
Among these types, H. influenzae type b (Hib) is the most common cause of invasive diseases, such as meningitis and bacteremia, especially in young children. The other types are less commonly associated with disease but can cause respiratory, ear, and sinus infections. Non-typeable H. influenzae (NTHi) lacks a capsule, is a periodic colonizer of the human respiratory tract, and can cause various infections.Â
H. influenzae is a mucosal parasite that causes disease in the upper respiratory system of healthy persons. Outer cell membrane consisting of Lip oligosaccharide in H. influenzae is majorly responsible for skin inflammation.
The strains generally identified are non-encapsulated. They are hardly virulent. IgA1 protease is produced in the meninges and respiratory tract mucosa as an affinity by H. influenzae. Pathogenicity can be determined by the primary determinant in which cell phagocytosis is prevented due to capsule protection.Â
 H. influenzae pathogenesis is not understood, although encapsulated type b (Hib) has a poly ribosyl ribitol phosphate capsule within them, these serotype causes conditions known as epiglottitis, which is meant to be a primary virulence factor.
The capsule of type b H. influenzae allows them to fight against complement-mediated lysis and phagocytosis in the host with nonimmunity. The unencapsulated strains are always less invasive. However, they can launch an inflammatory response in human subjects, which leads to various symptoms. Â
Hib conjugate vaccine is productive in inhibiting Hib infection, but it doesn’t prevent infections caused by NTHi strains. The non-encapsulated H. influenzae strain can also cause upper and lower respiratory tract infections, even in immunocompromised adults,Â
 Â
 Â
 
https://en.wikipedia.org/wiki/Haemophilus_influenzaeÂ
ď·źHYPERLINK “https://www.bing.com/search?q=Haemophilus+influenzae&qs=n&form=QBRE&sp=-1&lq=0&pq=haemophilus+influenzae&sc=12-22&sk=&cvid=D9768CDB72D94D519BA06020ACE24BDB&ghsh=0&ghacc=0&ghpl=”https://www.ncbi.nlm.nih.gov/books/NBK562176Â
Haemophilus. influenzae was early described by Richard Pfeiffer in 1893, all alone during an influenza pandemic. H. influenzae is accomplished only in human beings; it is a facultative anaerobic bacterium.Â
The animal reservoir has just been sourced for H. influenzae. These organisms spread from one person to another by direct contact, secretions, and via aerosol, which they colonize through the nasopharynx. Infected individuals, specifically those left untreated and with infections with poor immunity, spread the disease by respiratory droplets with H. influenzae.Â
Exposure criteria to H. influenzae are more in children. According to the 2017 annual report, the occurrence rate was 1.7 for non-b H. influenzae and 0.18 for Hib, and 1.6 for non-typeable H. influenzae, which affected 100,000 children under five years old. The carriage criteria are approximately 20% in juveniles and 1-year-old babies, increasing to about 50% in 5 years old children.Â
Healthy adults are also infected by Haemophilus influenzae, which spreads and colonizes by aerosol, direct and venereal contact, or through secretions. The colonization rate is higher in nontyable H. influenzae compared to type b H. influenzae. But still, both types multiply quickly and maintain a higher growth rate.Â
Scientific classification:Â Â
Kingdom: Bacteria Â
Phylum: Proteobacteria Â
Class: Gammaproteobacteria Â
Order: Pasteurellales Â
Family: Pasteurellaceae Â
Genus: Haemophilus Â
Species: Haemophilus influenzae Â
Structure:Â
Six known antigenic types of Haemophilus influenzae are identified by their capsular polysaccharides, which are important virulence factors. The six types are:Â
Among these types, H. influenzae type b (Hib) is the most common cause of invasive diseases, such as meningitis and bacteremia, especially in young children. The other types are less commonly associated with disease but can cause respiratory, ear, and sinus infections. Non-typeable H. influenzae (NTHi) lacks a capsule, is a periodic colonizer of the human respiratory tract, and can cause various infections.Â
H. influenzae is a mucosal parasite that causes disease in the upper respiratory system of healthy persons. Outer cell membrane consisting of Lip oligosaccharide in H. influenzae is majorly responsible for skin inflammation.
The strains generally identified are non-encapsulated. They are hardly virulent. IgA1 protease is produced in the meninges and respiratory tract mucosa as an affinity by H. influenzae. Pathogenicity can be determined by the primary determinant in which cell phagocytosis is prevented due to capsule protection.Â
 H. influenzae pathogenesis is not understood, although encapsulated type b (Hib) has a poly ribosyl ribitol phosphate capsule within them, these serotype causes conditions known as epiglottitis, which is meant to be a primary virulence factor.
The capsule of type b H. influenzae allows them to fight against complement-mediated lysis and phagocytosis in the host with nonimmunity. The unencapsulated strains are always less invasive. However, they can launch an inflammatory response in human subjects, which leads to various symptoms. Â
Hib conjugate vaccine is productive in inhibiting Hib infection, but it doesn’t prevent infections caused by NTHi strains. The non-encapsulated H. influenzae strain can also cause upper and lower respiratory tract infections, even in immunocompromised adults,Â
 Â
 Â
 
https://en.wikipedia.org/wiki/Haemophilus_influenzaeÂ
ď·źHYPERLINK “https://www.bing.com/search?q=Haemophilus+influenzae&qs=n&form=QBRE&sp=-1&lq=0&pq=haemophilus+influenzae&sc=12-22&sk=&cvid=D9768CDB72D94D519BA06020ACE24BDB&ghsh=0&ghacc=0&ghpl=”https://www.ncbi.nlm.nih.gov/books/NBK562176Â
Haemophilus. influenzae was early described by Richard Pfeiffer in 1893, all alone during an influenza pandemic. H. influenzae is accomplished only in human beings; it is a facultative anaerobic bacterium.Â
The animal reservoir has just been sourced for H. influenzae. These organisms spread from one person to another by direct contact, secretions, and via aerosol, which they colonize through the nasopharynx. Infected individuals, specifically those left untreated and with infections with poor immunity, spread the disease by respiratory droplets with H. influenzae.Â
Exposure criteria to H. influenzae are more in children. According to the 2017 annual report, the occurrence rate was 1.7 for non-b H. influenzae and 0.18 for Hib, and 1.6 for non-typeable H. influenzae, which affected 100,000 children under five years old. The carriage criteria are approximately 20% in juveniles and 1-year-old babies, increasing to about 50% in 5 years old children.Â
Healthy adults are also infected by Haemophilus influenzae, which spreads and colonizes by aerosol, direct and venereal contact, or through secretions. The colonization rate is higher in nontyable H. influenzae compared to type b H. influenzae. But still, both types multiply quickly and maintain a higher growth rate.Â
Scientific classification:Â Â
Kingdom: Bacteria Â
Phylum: Proteobacteria Â
Class: Gammaproteobacteria Â
Order: Pasteurellales Â
Family: Pasteurellaceae Â
Genus: Haemophilus Â
Species: Haemophilus influenzae Â
Structure:Â
Six known antigenic types of Haemophilus influenzae are identified by their capsular polysaccharides, which are important virulence factors. The six types are:Â
Among these types, H. influenzae type b (Hib) is the most common cause of invasive diseases, such as meningitis and bacteremia, especially in young children. The other types are less commonly associated with disease but can cause respiratory, ear, and sinus infections. Non-typeable H. influenzae (NTHi) lacks a capsule, is a periodic colonizer of the human respiratory tract, and can cause various infections.Â
H. influenzae is a mucosal parasite that causes disease in the upper respiratory system of healthy persons. Outer cell membrane consisting of Lip oligosaccharide in H. influenzae is majorly responsible for skin inflammation.
The strains generally identified are non-encapsulated. They are hardly virulent. IgA1 protease is produced in the meninges and respiratory tract mucosa as an affinity by H. influenzae. Pathogenicity can be determined by the primary determinant in which cell phagocytosis is prevented due to capsule protection.Â
 H. influenzae pathogenesis is not understood, although encapsulated type b (Hib) has a poly ribosyl ribitol phosphate capsule within them, these serotype causes conditions known as epiglottitis, which is meant to be a primary virulence factor.
The capsule of type b H. influenzae allows them to fight against complement-mediated lysis and phagocytosis in the host with nonimmunity. The unencapsulated strains are always less invasive. However, they can launch an inflammatory response in human subjects, which leads to various symptoms. Â
Hib conjugate vaccine is productive in inhibiting Hib infection, but it doesn’t prevent infections caused by NTHi strains. The non-encapsulated H. influenzae strain can also cause upper and lower respiratory tract infections, even in immunocompromised adults,Â
 Â
 Â
 
https://en.wikipedia.org/wiki/Haemophilus_influenzaeÂ
ď·źHYPERLINK “https://www.bing.com/search?q=Haemophilus+influenzae&qs=n&form=QBRE&sp=-1&lq=0&pq=haemophilus+influenzae&sc=12-22&sk=&cvid=D9768CDB72D94D519BA06020ACE24BDB&ghsh=0&ghacc=0&ghpl=”https://www.ncbi.nlm.nih.gov/books/NBK562176Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
